Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

High Practice Variability in Cerebral Palsy Diagnosis: Need for clarification of the consensus definition?
Child Neurology and Developmental Neurology
P5 - Poster Session 5 (8:00 AM-9:00 AM)
5-008
To examine practice variability in cerebral palsy (CP) diagnosis. 

Per the international consensus definition, CP "is not an etiologic diagnosis, but a clinical descriptive term" (Rosenbaum et al., 2007). A separate international consensus statement notes "genetic or other causation should not change the clinical diagnosis of CP" (MacLennan et al. 2019). However, it is unclear how these statements are applied in clinical practice.

We surveyed practitioners who commonly diagnose CP (Âé¶¹´«Ã½Ó³»­ Child Neurology Section via Synapse;  American Academy of Cerebral Palsy and Developmental Medicine via e-mail, n=1867). The survey supplied the consensus definition of CP and then asked respondents (n=216) to state whether they would diagnose CP in four hypothetical scenarios:

1: A 5 year old boy born at 30 weeks gestation with periventricular T2 hyperintensities on MRI, motor delays, and non-progressive spastic diplegia

2: Same as scenario 1 but with progressive spastic diplegia

3: Same as scenario 1 but with pathogenic mutations in ADD3 likely explaining his phenotype

4: A 5 year old boy born at 40 weeks gestation with a normal MRI, global delays, non-progressive generalized hypotonia, and a chromosome 1q deletion explaining his phenotype

Most diagnosed CP in scenario 1, but not scenario 2 (93%, 200/216). Despite being otherwise identical to scenario 1, the child in scenario 3 would not receive a CP diagnosis from a third of practitioners due to his genetic abnormality (35%, 75/216). Non-neurologists cited hypotonia, normal MRI, and/or genetic diagnosis as exclusion criteria for CP in scenario 4 (58%, 83/142), while neurologists tended to only cite genetic diagnosis (38%, 27/72), highlighting significant differences in approach (p<0.00005, Chi-square). 

There is dramatic practice variability in CP diagnosis despite explicit access to the CP consensus definition. Clarification of the consensus definition may help ensure uniformity of practice.

Authors/Disclosures
Bhooma R. Aravamuthan, MD, DPhil, FCNS, FÂé¶¹´«Ã½Ó³»­ (Washington University in St. Louis)
PRESENTER
The institution of Dr. Aravamuthan has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Aravamuthan has received research support from Child Neurology Foundation. The institution of Dr. Aravamuthan has received research support from American Board of Psychiatry and Neurology. The institution of Dr. Aravamuthan has received research support from Centers for Disease Control. Dr. Aravamuthan has received publishing royalties from a publication relating to health care.
No disclosure on file
Michael Kruer, MD (Sanford Children's Speciality Clinic) Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC Therapeutics. The institution of Dr. Kruer has received research support from NIH NINDs. The institution of Dr. Kruer has received research support from Medtronic . Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.